MyJournals Home  

RSS FeedsParkinson`s drug makers target inflammasome (Nature Biotechnology)

 
 

22 january 2019 04:02:03

 
Parkinson`s drug makers target inflammasome (Nature Biotechnology)
 




 
73 viewsCategory: Biotechnology
 
Biotech shockwaves follow BMS`s $74 billion Celgene buyout (Nature Biotechnology)
Publisher Correction: Radioactive drugs emerge from the shadows to storm the market (Nature Biotechnology)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Biotechnology


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten